Japan Launch- 15 Million cash milestone from Abbott now official.
These revs coming online in Q4. Japan has highest per capita pharmaceutical use in the the world. $15M milestone could get them to profitable quarter. Two follow-on sNDA approvals on tap between now and January for Amitiza and Rescula.
Lack of PPS movement today was unreal opportunity to buy more.